Turkish Journal of Pharmaceutical Sciences最新文献

筛选
英文 中文
Smartphone Digital Image Colorimetry for the Determination of Aluminum in Antiperspirant Products. 智能手机数字图像比色法测定止汗产品中铝的含量。
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-12-21 DOI: 10.4274/tjps.galenos.2021.18828
Suad Abughrin, Usama Alshana, Jude Caleb
{"title":"Smartphone Digital Image Colorimetry for the Determination of Aluminum in Antiperspirant Products.","authors":"Suad Abughrin,&nbsp;Usama Alshana,&nbsp;Jude Caleb","doi":"10.4274/tjps.galenos.2021.18828","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.18828","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to present a method for the determination of the aluminum in antiperspirant products (APPs) by chelating it with quercetin before its detection by smartphone digital image colorimetry (SDIC).</p><p><strong>Materials and methods: </strong>Samples were prepared by closed-vessel acid digestion in PTFE cups. This was followed by complexation of aluminum in the sample solution using quercetin as a chelating agent. Sample solutions were transferred into a quartz ultraviolet/visible detection microcuvette for detection in a homemade colorimetric box designed for capturing images of the yellow complex with a smartphone camera. The pixel intensity of the images was converted to numbers for quantitation using ImageJ software for a personal computer. An independent study using high-performance liquid chromatography-diode-array detection was conducted to check the accuracy of the proposed method.</p><p><strong>Results: </strong>Optimum SDIC conditions included a Samsung C9 smartphone as the detection camera, a cropped region of interest of 6400 px<sup>2</sup>, and the side position of the colorimetric box were selected for capturing the images of the sample solutions placed 10.0 cm from the detection camera, whereas optimum complexation conditions were found to be as sample pH of 5.5, sample volume of 3.0 mL, complexation time of 1.0 min and a ligand concentration of 0.28 mmol L<sup>-1</sup>. Analytical performance of the method included a limit of detection of 0.5 μmol L<sup>-1</sup> and a coefficient of determination (R<sup>2</sup>) of the calibration graph of 0.9981.</p><p><strong>Conclusion: </strong>The proposed method was successfully applied for the determination of aluminum in APPs with percentage recoveries ranging from 80.0 to 109.6%.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 6","pages":"618-625"},"PeriodicalIF":1.7,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780579/pdf/TJPS-19-618.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10799614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of Lonicera etrusca var. etrusca Santi (Caprifoliaceae) Stem and Leaf in Terms of Anatomical Structures and Some Phenolic Compounds. 从解剖结构和某些酚类化合物的角度评价刺槐科金银花的茎叶。
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-12-21 DOI: 10.4274/tjps.galenos.2021.71636
Derya Çiçek Polat, Muhammed Mesud Hürkul
{"title":"Evaluation of <i>Lonicera etrusca</i> var. <i>etrusca</i> Santi (Caprifoliaceae) Stem and Leaf in Terms of Anatomical Structures and Some Phenolic Compounds.","authors":"Derya Çiçek Polat,&nbsp;Muhammed Mesud Hürkul","doi":"10.4274/tjps.galenos.2021.71636","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.71636","url":null,"abstract":"<p><strong>Objectives: </strong>The genus <i>Lonicera</i> includes medicinally important plants. Two varieties of <i>L. etrusca</i> have been recorded in Türkiye. Anatomical structures and phytochemical contents are important in the diagnosis and identification of medicinal plants. This study included stem and leaf anatomy of <i>L. etrusca</i> var. etrusca and high performance liquid chromatography (HPLC) analysis of the methanol extracts obtained from these parts.</p><p><strong>Materials and methods: </strong>Plant materials were collected from Ankara. Methanol extracts were prepared from the stems and leaves by ultrasonic bath. The amounts of chlorogenic acid and caffeic acid that are major compounds in the stem and leaves, were determined by HPLC. For anatomical studies, specimens were preserved in 70% alcohol. Transverse and surface sections were prepared by hand. Detection of tissues was performed using Sartur reagent. Anatomical specimens were examined using a light microscope and microphotographed.</p><p><strong>Results: </strong>In HPLC analysis, the highest amount of chlorogenic acid was determined in the leaf (1.148%), and the highest amount of caffeic acid (0.156%) was determined in the stem. In the anatomical analysis, it was observed that the stem was disc-shaped and hollow; pericycle is in a ring form, consists of fibre-like cells with thick walls and wide lumina; cork occurs adjoining pericyclic fibers; thin-walled pith cells containing dense druse crystals. The leaf lamina is bifacial in the transverse section; palisade and spongy parenchyma, both contain abundant starch grains; solitary druse crystals are sparse in the leaf mesophyll; the stomata were observed only on the lower surface with 3-5 subsidiary cells. With this study, <i>L. etrusca</i> var. <i>etrusca</i> has been clarified in terms of its anatomical structures and phenolic compounds.</p><p><strong>Conclusion: </strong>The chemical contents and anatomical structures of the plant may contain important information that can be used in classification. This study may support in taxonomically classification for the <i>L. etrusca</i> var. etrusca.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 6","pages":"636-641"},"PeriodicalIF":1.7,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780581/pdf/TJPS-19-636.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10509336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Determination of Factors Influencing Pharmacists While Recommending Immune-Enhancing Products via Analytic Hierarchy Process. 运用层次分析法确定药师推荐免疫增强产品的影响因素。
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-12-21 DOI: 10.4274/tjps.galenos.2022.02686
Nilay Tarhan, Miray Arslan
{"title":"Determination of Factors Influencing Pharmacists While Recommending Immune-Enhancing Products <i>via</i> Analytic Hierarchy Process.","authors":"Nilay Tarhan,&nbsp;Miray Arslan","doi":"10.4274/tjps.galenos.2022.02686","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2022.02686","url":null,"abstract":"<p><strong>Objectives: </strong>Immune enhancers are attracting attention day by day. Besides, during the coronavirus disease-2019 (COVID-19) pandemic, there has been an increasing demand for immune enhancers. Pharmacists are seen as trustable providers of complementary and alternative medicines, dietary and herbal supplements, immune-enhancers, and so on. This study aims to prioritization criteria that affect community pharmacists' recommending behavior regarding immune enhancers.</p><p><strong>Materials and methods: </strong>This paper adopts the analytic hierarchy process (AHP) to rank different criteria substantial for affecting community pharmacists' recommending behavior regarding immune enhancers. In this direction, firstly seven criteria were identified through literature review and views of pharmacists who have community pharmacy experiences. These are; (i) ease of access, (ii) selling price, (iii) package, (iv) content (appropriateness to patient health status), (v) expectation of patient, (vi) quality, and (vii) trust in the manufacturer. Then, a questionnaire including criteria was prepared and delivered to community pharmacists. The data obtained from 93 participants were transferred to the Super Decisions software. The hierarchical structure of the AHP was established and pair-wise comparisons were made.</p><p><strong>Results: </strong>This study showed that the most important criterion was the ease of access (28%). Secondly, pharmacists give importance to the content of the product, while advising immune-enhancers (22%). Besides, it was determined that the least important criterion was the package of the product (4%).</p><p><strong>Conclusion: </strong>This study will contribute to the literature by facilitating the process of assessing factors that pharmacists pay attention to while recommending immune-enhancing products. Additionally, the present study results will shed light on firms producing such products, to shape their supply chain management strategies, especially for marketing and sales.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 6","pages":"701-705"},"PeriodicalIF":1.7,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780582/pdf/TJPS-19-701.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10452331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Peptide Sequence of Pili Subunit Protein 49.8 kDa Shigella flexneri as Antigenic Epitope for Shigellosis Vaccine Development. 志贺氏菌菌毛亚基蛋白49.8 kDa作为志贺氏菌疫苗抗原表位的肽序列
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-12-21 DOI: 10.4274/tjps.galenos.2021.75031
Khoirul Anam, Agustina Tri Endharti, Sri Poeranto, Sumarno Reto Prawiro
{"title":"Peptide Sequence of Pili Subunit Protein 49.8 kDa <i>Shigella flexneri</i> as Antigenic Epitope for Shigellosis Vaccine Development.","authors":"Khoirul Anam,&nbsp;Agustina Tri Endharti,&nbsp;Sri Poeranto,&nbsp;Sumarno Reto Prawiro","doi":"10.4274/tjps.galenos.2021.75031","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.75031","url":null,"abstract":"<p><strong>Objectives: </strong>This study investigates the amino acid sequence and identifies antigenic epitopes of 49.8 kilodalton (kDa) pili protein <i>Shigella flexner</i>i, which will be used as candidates for the shigellosis vaccine.</p><p><strong>Materials and methods: </strong>Our study is a prospectively descriptive laboratory. We used bacterial isolate of <i>S. flexneri</i> pili isolation was performed using a pili cutter and sodium dodecyl-sulfate polyacrylamide gel electrophoresis. The amino acid sequences were analyzed using liquid chromatography dual mass spectrometry (LC-MS/MS) method in the proteomic laboratory. The target epitope antigenicity analysis was tested using Kolaskar and Tongaonkar Antigenicity software. The Bepired Linear Epitope Prediction software is used for epitope mapping. PymOL software was used for the visualization of proteins and molecular docking. Peptides and antibodies were applied to hemagglutination test and immune response was tested using the dot blot method.</p><p><strong>Results: </strong>LC-MS/MS analysis results from the mascot server showed that the 49.8 kDa pili protein is <i>S. flexneri</i> similar to the flagellin protein of <i>S. flexneri</i> 1235-66 (ID I6H2T2). The results of antigenicity analysis and epitope mapping showed that areas of protein that has the most potential and antigenic epitopes are the regions 98-111 and 263-290 with the amino acid sequences, <i>QSSTGTNSQSDLDS</i> (Q-S) and <i>DTTITKAETKTVTKNQVVDTPVTTDAAK</i> (D-K). The results of the molecular docking interaction test between the peptide and the B-cell receptor have a low binding energy. Peptide Q-S and peptide D-K antigens are hemagglutinin molecules because they can agglutinate erythrocytes. The immune response between peptide antigens and anti-peptide antibodies can react based on color gradations in the dotblot method.</p><p><strong>Conclusion: </strong>The amino acid sequences Q-S and D-K are potentially antigenic epitopes. These peptides can be used to develop candidates for shigellosis vaccine.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 6","pages":"649-656"},"PeriodicalIF":1.7,"publicationDate":"2022-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780573/pdf/TJPS-19-649.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10509338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Biodegredable Microparticles for Mucosal Vaccination Against Diphtheria Toxoid: Nasal Efficacy Studies in Guinea Pigs 生物可降解微粒用于白喉类毒素粘膜疫苗接种的评价:豚鼠鼻腔疗效研究
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-12-14 DOI: 10.4274/tjps.galenos.2022.05626
Selin Çoban, O. M. Saka, A. Bozkır
{"title":"Evaluation of Biodegredable Microparticles for Mucosal Vaccination Against Diphtheria Toxoid: Nasal Efficacy Studies in Guinea Pigs","authors":"Selin Çoban, O. M. Saka, A. Bozkır","doi":"10.4274/tjps.galenos.2022.05626","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2022.05626","url":null,"abstract":"Introduction: In this study, Poly-(ɛ-caprolactone) (PCL) and Poly-(lactic-co-glycolic acid) (PLGA) microparticles encapsulating diphtheria toxoid (DT) were investigated for their potential as a mucosal vaccine delivery system. Materials and Methods: The antigen-containing microparticles were prepared using double emulsion (w/o/w) solvent evaporation method. Results: The average geometric diameter of the particles were found between 7 and 24 µm which is suitable for uptake by the antigen presenting cells in the nasal mucosa. Although the differences were not significant, PLGA polymer containing formulations exhibited the highest encapsulation efficiency. The microparticle formulations, prepared with both PLGA and PCL polymers, was successfully produced at high production yields. The in vitro release profile was presented as a biexponential process with an initial burst effect due to the release of the protein adsorbed on the microsphere surface and the subsequent sustained release profile is the result of protein diffusion through the channels or pores formed in the polymer matrix. DT loaded microparticles, DT solution in phosphate buffered saline and empty microparticles (as control) were administered via nasal route and subcutaneously to guinea pigs. The antibody content of each serum sample was determined by an enzyme-linked immunosorbent assay. Conclusion: Absorbance values of ELISA test showed that PLGA and PCL bearing microparticles were able to stimulate adequate systemic immune response with intranasal vaccination. Additionally, PLGA and PCL microparticles resulted in significantly increased IgG titers with intranasal administration as a booster dose following subcutaneous administration. PCL polymer elicited a high immune response compared to PLGA polymer (p<0,05).","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"1 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2022-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42708173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of Forskolin Microemulsion Formula and its Irritation Test on Rabbits 毛喉素微乳制剂的研制及其对家兔的刺激性试验
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-12-01 DOI: 10.4274/tjps.galenos.2022.73373
Rahma Nafiah, Y. Sumirtapura, S. T. Darijanto, M. Iwo
{"title":"Development of Forskolin Microemulsion Formula and its Irritation Test on Rabbits","authors":"Rahma Nafiah, Y. Sumirtapura, S. T. Darijanto, M. Iwo","doi":"10.4274/tjps.galenos.2022.73373","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2022.73373","url":null,"abstract":"Objective: This study aims to develop a microemulsion formula that can increase the solubility and stability of forskolin and is safe for topical use. Materials and Methods: The materials used for the development of the microemulsion formula were triglyceride oil, nonionic surfactants, and polyethylene glycol for cosurfactants which were selected based on the results of the forskolin solubility test using high performance liquid chromatography. Microemulsion was formulated by phase titration method. Formula stability was determined on storage for 90 days at refrigerator, room temperature","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43304707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of Project-based learning (PBL) for Pharmacy Education 项目学习对药学教育的重要性
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-11-08 DOI: 10.4274/tjps.galenos.2022.69023
K. Ashiq
{"title":"Importance of Project-based learning (PBL) for Pharmacy Education","authors":"K. Ashiq","doi":"10.4274/tjps.galenos.2022.69023","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2022.69023","url":null,"abstract":"Project-based learning (PBL) is defined as a question-based teaching approach that ensures the active participation of the learners in building knowledge by enabling them to carry out meaningful projects and develop concrete products. Project-based learning (PBL) is generally regarded as an alternative to the traditional teaching provided by teachers. It is recognized that project-based learning (PBL) is a favorable approach that enhances student learning in higher education. 1 Project-based learning (PBL) was incorporated into educational practice in early 1980s. The history of project-based learning (PBL) has its roots in the progressive tradition encouraged by John Dewey. He emphasized the concept of \"learning through practice\". John Dewey maintained that the lecture room should be a sort of society and in the learning process the focus should be on the students. Project-based learning (PBL) is a highly efficient technique that allows students; to express their views on topics that cover areas of their interest, to raise their queries","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":" ","pages":""},"PeriodicalIF":1.7,"publicationDate":"2022-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47081799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Stability Indicating Assay Method for the Quantitative Determination of Olaparib in Bulk and Pharmaceutical Dosage Form. 原料药和制剂奥拉帕尼定量测定的稳定性指示法。
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-10-31 DOI: 10.4274/tjps.galenos.2021.48861
Antima Chaudhary, Rajiv Tonk, Pankaj Dagur, Suddhasattya Dey, Manik Ghosh
{"title":"Stability Indicating Assay Method for the Quantitative Determination of Olaparib in Bulk and Pharmaceutical Dosage Form.","authors":"Antima Chaudhary,&nbsp;Rajiv Tonk,&nbsp;Pankaj Dagur,&nbsp;Suddhasattya Dey,&nbsp;Manik Ghosh","doi":"10.4274/tjps.galenos.2021.48861","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.48861","url":null,"abstract":"<p><strong>Objectives: </strong>Olaparib is an orally active poly (ADP-ribose) PARP (polymerases) inhibitor known to destroy cancer cells with BRCA1 or BRCA2 deficiency. An authentic, fast, distinct, and reliable reverse phase-high performance liquid chromatography (RP-HPLC) method was developed and promptly validated in tablet formulations for olaparib estimation.</p><p><strong>Materials and methods: </strong>The proposed method focuses on the separation of olaparib in reverse phase mode using a Waters symmetry C18 (150 x 4.6 mm, 5 μm) analytical column with a flow rate of 1.0 mL/min and the injection volume was kept at 20 μL. The optimized mobile phase consists of ammonium acetate buffer (pH adjusted to 3.5 by glacial acetic acid): methanol in the ratio of 50:50 v/v.</p><p><strong>Results: </strong>The eluents were measured at 254 nm and the retention time for the drug encircled was about 4.32 min. The stress degradation studies of olaparib were conducted under acidic, alkaline, oxidative, photolytic and thermal conditions to demonstrate the stability of the drug. The regression value of 0.998 showed that the developed method was linear over the range of 80 μg/mL to 120 μg/mL. The developed RP-HPLC method is accurate and precise. The method was statistically validated as per International Conference on Harmonization guidelines.</p><p><strong>Conclusion: </strong>The proposed method is suitable and can be applied for the quantitative estimation of olaparib without any interference of the excipients used in the drug formulations.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"488-497"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634445/pdf/TJPS-19-488.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40659552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Tableting Performance of Maize and Potato Starches Used in Combination as Binder/Disintegrant in Metronidazole Tablet Formulation. 玉米、马铃薯淀粉复合作甲硝唑片粘结剂/崩解剂的压片性能研究
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-10-31 DOI: 10.4274/tjps.galenos.2021.47855
Yonni Eshovo Apeji, Rejoice Thomas Kaigama, Sani Hadi Ibrahim, Sophie Nock Anyebe, Aisha Ohunene Abdussalam, Avosuahi Rukayat Oyi
{"title":"Tableting Performance of Maize and Potato Starches Used in Combination as Binder/Disintegrant in Metronidazole Tablet Formulation.","authors":"Yonni Eshovo Apeji,&nbsp;Rejoice Thomas Kaigama,&nbsp;Sani Hadi Ibrahim,&nbsp;Sophie Nock Anyebe,&nbsp;Aisha Ohunene Abdussalam,&nbsp;Avosuahi Rukayat Oyi","doi":"10.4274/tjps.galenos.2021.47855","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.47855","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to characterize the tableting performance of maize and potato starches, when used in combination either as a disintegrant or binder in solid dosage form development.</p><p><strong>Materials and methods: </strong>Wet granulation was used to process metronidazole granules incorporating either maize starch, potato starch, or a combination of the two starches as binders or disintegrant at 10% <sup>w</sup>/<sub>w</sub>. Granule analysis was carried out on the various formulations and subsequently compressed into tablets weighing approximately 500 mg following the addition of extragranular excipients. Tablet properties were assessed after 24 h of storage.</p><p><strong>Results: </strong>Analysis of granule properties did not reveal a wide variation across the formulations irrespective of the type and combination of starches used in the formulation either as binder or disintegrant. It was observed, however, that there were slight differences in particle size, bulk and tapped densities of granule formulations containing the combined starch as excipients compared to granule formulations containing individual starch as the excipient. Tablets prepared using the combined starches as binder had lower tensile strength and disintegration time compared to other formulations incorporating the individual starches as binders. However, when evaluated as disintegrant, the tablet formulation containing the combined starches produced tablets with relatively lower disintegration time compared to formulations containing the individual starches as disintegrant.</p><p><strong>Conclusion: </strong>The study concludes that the combination of maize and potato starches as excipients in tablet formulation influenced the outcome of granule and tablet properties.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"513-520"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634452/pdf/TJPS-19-513.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40660461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hepcidin as a Potential Biomarker for the Diagnosis of Anemia. Hepcidin作为诊断贫血的潜在生物标志物。
IF 1.7
Turkish Journal of Pharmaceutical Sciences Pub Date : 2022-10-31 DOI: 10.4274/tjps.galenos.2021.29488
Zainab H Fathi, Jehan A Mohammad, Zaid M Younus, Sameer M Mahmood
{"title":"Hepcidin as a Potential Biomarker for the Diagnosis of Anemia.","authors":"Zainab H Fathi,&nbsp;Jehan A Mohammad,&nbsp;Zaid M Younus,&nbsp;Sameer M Mahmood","doi":"10.4274/tjps.galenos.2021.29488","DOIUrl":"https://doi.org/10.4274/tjps.galenos.2021.29488","url":null,"abstract":"<p><p>There are several blood-based markers to assess iron stores, but they all have some limitations. Hepcidin, a low-molecular-weight peptide hormone, is produced mainly by the liver. It is the main regulator of iron homeostasis by preventing iron release into plasma from absorptive enterocytes and macrophages. This review aims to critically assess existing data on potential role of hepcidin in diagnosis, particularly the (pre) analytical implications of the hepcidin measurement. There is a well-known causative correlation between hepcidin and iron deficiency. Therefore, hepcidin is considered as a promising marker in the assessment of iron status, particularly in patients with a diagnostic dilemma, such as patients with chronic renal disease and infants. The clinical implications of this peptide hormone in diagnosis of other diseases have been expanded in the recent studies, including elevated hepcidin levels in neoplastic diseases, sepsis, and inflammation. The potential role of hepcidin in diagnosis is controversial in the various types of iron deficiency because data are conflicting (as in anaemia of chronic disease) or limited (as in infants), whereas in the case of hereditary haemochromatosis, it has been proposed that hepcidin may be used for stratification of molecular testing, or to improve the frequency of phlebotomy, however, this issue still needs to be investigated. Due to lack of a clinically approved test, the medical application of this peptide as a biomarker in diagnosis is restricted. Recently, assays have been developed to determine hepcidin levels in serum and urine, facilitating the future use of hepcidin in research and clinical practice.</p>","PeriodicalId":23378,"journal":{"name":"Turkish Journal of Pharmaceutical Sciences","volume":"19 5","pages":"603-609"},"PeriodicalIF":1.7,"publicationDate":"2022-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634449/pdf/TJPS-19-603.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信